Insider Trading July 10, 2026 04:36 PM

Olesen Value Fund L.P. Trims Solitron Devices Stake Following Recent Rally

The 10% shareholder reduced its position by $361,181 across two transactions in July 2026, citing valuation concerns per InvestingPro analysis.

By Maya Rios
Share
Twitter Reddit Facebook LinkedIn
SODI

Olesen Value Fund L.P., a major stakeholder in Solitron Devices Inc. (NASDAQ:SODI), executed a divestment of common stock valued at $361,181. The transactions took place on July 8 and July 10, 2026, reducing the fund's direct and indirect holdings in the semiconductor and related devices manufacturer. This sale occurs after a significant price appreciation for SODI, with the stock gaining 67.5% over the past year and 41% in the last six months. According to InvestingPro analysis, the stock may be overvalued relative to its Fair Value, a factor potentially influencing the decision to reduce the position.

Olesen Value Fund L.P. Trims Solitron Devices Stake Following Recent Rally
SODI
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Olesen Value Fund L.P. sold $361,181 of Solitron Devices stock over two days in July 2026.
  • The stock has gained 67.5% over the past year and 41% in the last six months.
  • InvestingPro analysis suggests the stock may be overvalued relative to its Fair Value.

Olesen Value Fund L.P., a significant shareholder in Solitron Devices Inc. (NASDAQ:SODI), has reported the sale of $361,181 worth of the company's common stock. The transactions were executed over two distinct days, July 8 and July 10, 2026. As a 10% owner, the investment fund disposed of shares at prices ranging from $26.54 to $26.85 per share. These sales have directly reduced Olesen Value Fund L.P.'s direct and indirect holdings in the semiconductor and related devices manufacturer.

Key Points

  • The fund sold 3,017 shares on July 8, 2026, at a price of $26.85 each.
  • An additional 350 shares were sold on July 10, 2026, at $26.54 per share.
  • Following these transactions, Olesen Value Fund L.P. holds 222,931 shares of Solitron Devices common stock.

The timing of these sales coincides with a notable upward trajectory for Solitron Devices. The stock has delivered a 67.5% return over the past year and achieved a 41% gain in the last six months alone. According to InvestingPro analysis, the stock currently appears overvalued relative to its Fair Value. This valuation metric may have influenced the fund's decision to reduce its position. InvestingPro offers 11 additional exclusive tips for SODI, along with comprehensive financial health scores for investors seeking deeper insights.

Risks and Uncertainties

  • The filing indicates that Olesen Value Fund GP LLC serves as the general partner of Olesen Value Fund L.P., while Olesen Capital Management LLC acts as its investment manager.
  • Christian Olesen is the managing member of both Olesen Value Fund GP LLC and Olesen Capital Management LLC.
  • Each reporting person disclaims beneficial ownership of the reported shares except to the extent of their pecuniary interest.

The filing was submitted jointly by Olesen Value Fund L.P., Olesen Value Fund GP LLC, Olesen Capital Management LLC, and Christian Olesen. The sale of SODI stock impacts the semiconductor sector, where valuation metrics and insider activity are closely monitored for signals on future price movements. The reported transactions provide insight into the internal confidence and valuation perceptions held by a significant shareholder in the company.

Risks

  • The fund disclaims beneficial ownership of the reported shares except to the extent of their pecuniary interest.
  • The filing was submitted jointly by multiple entities, including Olesen Value Fund GP LLC and Olesen Capital Management LLC.
  • Christian Olesen is the managing member of both Olesen Value Fund GP LLC and Olesen Capital Management LLC.

More from Insider Trading

Globalharvest Holdings Expands Mission Produce Stake With $7.87 Million Share Purchase Jul 10, 2026 Riskified Director Shachar Erez Offloads $671K in Shares Under Pre-Arranged Plan Jul 10, 2026 Contineum Therapeutics CSO Executes Pre-Arranged Stock Sales Following Option Exercises Jul 10, 2026 Petco Health & Wellness CHRO Offloads $508K in Stock Amid Market Volatility Jul 10, 2026 Gloo Holdings Executive Chair Expands Stake Amid Public Offering Jul 10, 2026